Edwards Lifesciences (EW) Work In Process (2010 - 2026)

Edwards Lifesciences has reported Work In Process for 13 years, with the latest figure at $234.8 million in Q2 2026.

• On a quarterly basis, Work In Process fell 10.18% year-over-year to $234.8 million in Q2 2026; TTM through Jun 2026 was $234.8 million, a 10.18% decrease from a year earlier, with the FY2025 full-year figure at $252.9 million, up 7.07% from the prior year.
• Work In Process was $234.8 million for Q2 2026 at Edwards Lifesciences, down from $242.2 million in the prior quarter.
• The five-year high for Work In Process was $275.9 million in Q3 2025, with the low at $195.8 million in Q4 2023.
• Average Work In Process over 4 years is $245.5 million, with a median of $244.4 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Work In Process advanced 20.63% in 2024, then retreated 10.18% in 2026.
• Over 4 years, Work In Process stood at $195.8 million in 2023, then climbed by 20.63% to $236.2 million in 2024, then rose by 7.07% to $252.9 million in 2025, then slipped by 7.16% to $234.8 million in 2026.
• The last three Work In Process figures came in at $234.8 million (Q2 2026), $242.2 million (Q1 2026), and $252.9 million (Q4 2025), per Business Quant data.